Heart Analysis in GATED-PET in Patients Having a Gallium-68-DOTATOC PET/CT Exam for Oncology Indication

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentral Hospital, Nancy, France

About this trial

Gallium-68-DOTATOC binds primarily with high affinity to somatostatin subtype 2 (SSTR2) receptors and these somatostatin receptors are also overexpressed on inflammation cells when activated.

The hypothesis is that the GATED mode on a Gallium-68-DOTATOC cardiac recording would be able to highlight abnormalities that could be correlated with the age of the patients and their cardiovascular risk factors.

Eligibility criteria

Qualifiers

Age ≥ 18 years old.

Having read and understood the information document.

Affiliated to a social security scheme.

Disqualifiers

Hypersensitivity during previous use of 68Ga-DOTATOC

Impossibility of performing a PET-CT (patient agitated, confused, etc.).

History of heart disease,

Severe arrhythmia that does not allow the PET synchronized with the ECG

Trial design

Treatments tested in this trial

  • Cardiac ECG-gated PET imaging will added

Treatment groups

99 Participants
are divided into 1 treatment group